Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Orgovyx (relugolix)
i
Other names:
RVT-601, TAK 385 , TAK-385, RVT 601, MVT-601, T-1331285, MVT 601, MVT601, T 1331285, T1331285, RVT601, TAK385
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
ASKA Pharma, Gedeon Richter, Intas, Knight Therap, Pfizer, Sumitomo Pharma, Takeda
Drug class:
GnRH antagonist
Related drugs:
‹
degarelix (3)
cetrorelix (0)
abarelix (0)
SHR7280 (0)
VERU-100 (0)
linzagolix (0)
ARD-03 (0)
degarelix (3)
cetrorelix (0)
abarelix (0)
SHR7280 (0)
VERU-100 (0)
linzagolix (0)
ARD-03 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Prostate Cancer
No biomarker
Prostate Cancer
relugolix
Sensitive: A1 - Approval
relugolix
Sensitive
:
A1
relugolix
Sensitive: A1 - Approval
relugolix
Sensitive
:
A1
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.